AI Bias Analysis
4 models · Takes ~15 seconds
(MedPage Today) -- CHICAGO -- A randomized trial testing the addition of selinexor (Xpovio) to ruxolitinib (Jakafi) for myelofibrosis only met one of its two primary endpoints, yet the combination also showed a potential survival benefit. At...
Source
MedPage Today
Opens original article in a new tab
(MedPage Today) -- Last summer, the Kiel Institute, a non-profit think tank in Germany, asked me to lead an analysis of the global benefits of international health aid programs, such as the Global Fund, the President's Emergency Plan for AIDS Relief...
(MedPage Today) -- In "Beyond Diagnosis: Vaccines," Cleveland Clinic infectious disease specialist Donald Dumford III, MD, and host John Mangels continue their conversations on communicating effectively and empathetically with patients around vaccination...
(MedPage Today) -- For egg-allergic children, an oral immunotherapy (OIT) protocol using low-dose liquid egg to start appeared to be the most successful in inducing tolerance in the outpatient setting, according to one academic center's experience...
(MedPage Today) -- CHICAGO -- A month-long structured yoga program helped patients with cancer improve mood disturbance, anxiety, and fatigue, contributing to a reduction in insomnia, a large multicenter randomized trial showed. Scores on tests...
